Ticker brief
TNGX TANGO THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$23.34
1 day
-16.4%
14 days
-2.0%
mkt cap
$4.8B
signals 14d
20
authors 14d
9
crowd 14d
-2.7σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 135% | IV/HV 1.98× (as of 2026-10-22) |
| Skew — 25Δ RR 30d | -0.156 | 25Δ call IV − put IV |
| Net dealer OI (NDOI) | +0.20 elevated | 5-session Δ n/a (as of 2026-06-26) |
| OI alarm | quiet | last alarm 2026-06-09 (z=2.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-06 → 2026-10-16 · now +0.18 (−1 bearish … +1 bullish)
Who spoke9
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @bioinvestor24 | A | -0.87 | 6 | +0.37 |
| @semodough | C | -1.06 | 4 | +0.11 |
| @Pharmdca | C | -3.41 | 3 | +0.67 |
| @Quantumup1 | C | +0.10 | 2 | +0.20 |
| @bullishchart | C | -1.21 | 1 | -0.20 |
| @OptionsFlowBoss | C | · | 1 | +0.00 |
| @PolycarpFX | B | +0.16 | 1 | +0.30 |
| @OzmosiHealth | C | · | 1 | +0.10 |
| @BiopharmIQ | B | · | 1 | +0.00 |
Recent signals20of 20 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @Pharmdca | +0.60 | Discloses an existing TNGX long while watching TNGX and MRNA into ESMO. | +5.9% | tweet ↗ |
| 2026-10-16 | @BiopharmIQ | +0.00 | The post summarizes opening biotech moves and their company-specific catalysts. | +5.9% | tweet ↗ |
| 2026-10-16 | @OzmosiHealth | +0.10 | Tango will present updated combination data at ESMO 2026. | +5.9% | tweet ↗ |
| 2026-10-16 | @bioinvestor24 | +0.00 | States TNGX's abstract used an April cutoff and an updated-data poster is due next Friday. | +5.9% | tweet ↗ |
| 2026-10-16 | @semodough | +0.10 | Tango will present updated vopimetostat combination data at ESMO 2026. | +5.9% | tweet ↗ |
| 2026-10-16 | @semodough | +0.25 | A Cantor survey ranks favorite and least-favorite SMID-cap biotech stocks. | +5.9% | tweet ↗ |
| 2026-10-15 | @bioinvestor24 | +0.15 | Compares oncology response and toxicity data, praising VSTM efficacy while flagging vomiting and liver-enzyme risks. | +2.8% | tweet ↗ |
| 2026-10-15 | @bioinvestor24 | +0.15 | Compares upcoming pan-RAS datasets and says response durability will determine competitive positioning. | +2.8% | tweet ↗ |
| 2026-10-13 | @PolycarpFX | +0.30 | Reports TNGX as a top purchase by Commodore Capital. | +5.0% | tweet ↗ |
| 2026-10-13 | @bioinvestor24 | +0.70 | Add to small biotech positions as pressure shifts toward big pharma. — Explicitly calls the setup an opportunity to add to small positions after contrasting biotech assets with big pharma. | +5.0% | tweet ↗ |
| 2026-10-13 | @Quantumup1 | +0.00 | Clarifies the study associated with conference abstract 3149P. | +5.0% | tweet ↗ |
| 2026-10-13 | @Quantumup1 | +0.40 | JPMorgan places TNGX on Positive Catalyst Watch while retaining Overweight and $48 PT. | +5.0% | tweet ↗ |
| 2026-10-10 | @OptionsFlowBoss | +0.00 | Gamma heat-zone chart is shared without a stated directional interpretation. | -2.0% | tweet ↗ |
| 2026-10-09 | @bullishchart | -0.20 | Reports the R&D president sold $660,000 in shares, alongside a bullish volume scan. | -2.0% | tweet ↗ |
| 2026-10-09 | @bioinvestor24 | +0.70 | Calls unspecified TNGX news excellent ahead of its ESMO presentation. | -2.0% | tweet ↗ |
| 2026-10-09 | @semodough | +0.10 | Provides JPMorgan's detailed ESMO catalyst schedule and says the first abstract likely will not move shares. | -2.0% | tweet ↗ |
| 2026-10-08 | @bioinvestor24 | +0.50 | Reports the CRO gave a positive preview of an upcoming combination update. | +3.4% | tweet ↗ |
| 2026-10-08 | @Pharmdca | +0.65 | Selectively buying biotech names during the pullback. — Explicitly discloses ongoing purchases; ticker output is capped at six. | +3.4% | tweet ↗ |
| 2026-10-06 | @Pharmdca | +0.75 | Adding to existing positions in INBX, ERAS, KURA, TNGX and BBIO. — Explicitly reports current additions to five biotech positions. | +6.6% | tweet ↗ |
| 2026-10-06 | @semodough | +0.00 | Announces a JPMorgan-hosted Tango Therapeutics CEO call on October 9 at 10 a.m. ET. | +6.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.